Filing Flows › Karyopharm Therapeutics (KPTI) › Recalls, complaints & regulation
Karyopharm Therapeutics (KPTI): clinical trials
Karyopharm Therapeutics (KPTI) beyond its filings: 8 active clinical trials.
Karyopharm Therapeutics' latest quarter
Karyopharm Therapeutics, Q2 2026: revenue $33.4M (-12% year over year), operating margin -67.4%, net loss $67.0M, operating cash flow −$24.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Karyopharm Therapeutics have?
8 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.